261 related articles for article (PubMed ID: 16649550)
1. Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials.
Song M; Liebenberg W; De Villiers MM
Pharmazie; 2006 Apr; 61(4):336-40. PubMed ID: 16649550
[TBL] [Abstract][Full Text] [Related]
2. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
3. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
Shelke NB; Aminabhavi TM
Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
[TBL] [Abstract][Full Text] [Related]
5. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
6. Erythritol: crystal growth from the melt.
Lopes Jesus AJ; Nunes SC; Ramos Silva M; Matos Beja A; Redinha JS
Int J Pharm; 2010 Mar; 388(1-2):129-35. PubMed ID: 20045045
[TBL] [Abstract][Full Text] [Related]
7. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
Pöllänen K; Häkkinen A; Reinikainen SP; Rantanen J; Karjalainen M; Louhi-Kultanen M; Nyström L
J Pharm Biomed Anal; 2005 Jun; 38(2):275-84. PubMed ID: 15925219
[TBL] [Abstract][Full Text] [Related]
8. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
[TBL] [Abstract][Full Text] [Related]
9. Determination of the physical state of drug in microcapsule and microsphere formulations.
Dash AK
J Microencapsul; 1997; 14(1):101-12. PubMed ID: 8994079
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
[TBL] [Abstract][Full Text] [Related]
11. Effect of bee venom peptide-copolymer interactions on thermosensitive hydrogel delivery systems.
Qiao M; Chen D; Hao T; Zhao X; Hu H; Ma X
Int J Pharm; 2007 Dec; 345(1-2):116-24. PubMed ID: 17629639
[TBL] [Abstract][Full Text] [Related]
12. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
13. [X-ray diffractometry in the analysis of drugs and pharmaceutical forms].
Bettinetti GP
Boll Chim Farm; 1989 May; 128(5):149-62. PubMed ID: 2690894
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of blends of paracetamol and citric acid.
Hoppu P; Jouppila K; Rantanen J; Schantz S; Juppo AM
J Pharm Pharmacol; 2007 Mar; 59(3):373-81. PubMed ID: 17331340
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
16. Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide).
Shen H; Hu X; Yang F; Bei J; Wang S
Biomaterials; 2007 Oct; 28(29):4219-30. PubMed ID: 17618682
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
19. Thermal degradation of amorphous glibenclamide.
Rehder S; Sakmann A; Rades T; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):203-8. PubMed ID: 21907802
[TBL] [Abstract][Full Text] [Related]
20. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
Li Y; Chow PS; Tan RB
Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
